Harris & Harris Group Inc.

PRESS RELEASE

HARRIS & HARRIS GROUP, INC.	JANUARY 16, 2003
ONE ROCKEFELLER PLAZA
NEW YORK, NEW YORK 10020
NASDAQ/NMS SYMBOL: TINY
CONTACT: MEL P. MELSEHIMER
TEL. NO. (212) 332-3614

HARRIS & HARRIS GROUP NOTES NANOGRAM PATENT ON MEDICAL POWER SOURCES

Harris & Harris Group, Inc. noted today the announcement by NanoGram Devices Corporation that it has received an additional U.S. patent for its novel power sources for medical devices. Newly issued Patent 6,503,646, "High Rate Batteries," details some of the performance parameters of the company's advanced batteries for defibrillators and pacemakers and similar medical devices. Please see the company's press release on www.nanogramdevices.com.

As Harris & Harris Group noted in a press release on December 3, 2002, NanoGram is a recent spinout of NeoPhotonics Corporation. Harris & Harris Group has invested $1,000,000 in NeoPhotonics (www.neophotonics.com).

Harris & Harris Group is a publicly traded venture capital company. The Company now makes initial investments exclusively in tiny-technology enabled companies, and its last eight initial private equity investments have been in such companies.

Harris & Harris Group, Inc. is a Business Development Company with 11,498,845 common shares outstanding.

Detailed information about Harris & Harris Group, Inc. and its holdings can be found on its website at http://www.TinyTechVC.com.

This press release may contain statements of a forward-looking nature relating to future events. Statements contained in this press release that are forward looking statements are intended to be made pursuant to the Safe Harbor Provisions for the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K and recent Prospectus filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc. undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.